Feld Michael (CIK 2034349) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-26). Recent activity: Sell BDX (75 shares), Sell BDX (74 shares), Sell BDX (75 shares), Sell BDX (75 shares), Sell BDX (75 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | BECTON DICKINSON & CO (BDX) | EVP, Chief Revenue Officer | Sell | 75 | $11,460 |
| 2026-04-28 | BECTON DICKINSON & CO (BDX) | EVP, Chief Revenue Officer | Sell | 74 | $11,244 |
| 2026-03-27 | BECTON DICKINSON & CO (BDX) | EVP, Chief Revenue Officer | Sell | 75 | $11,762 |
| 2026-02-27 | BECTON DICKINSON & CO (BDX) | EVP, Chief Revenue Officer | Sell | 75 | $13,638 |
| 2026-01-28 | BECTON DICKINSON & CO (BDX) | EVP, CRO & Pres. Life Sciences | Sell | 75 | $15,205 |
| 2025-12-29 | BECTON DICKINSON & CO (BDX) | EVP, CRO & Pres. Life Sciences | Sell | 74 | $14,510 |
| 2025-12-02 | BECTON DICKINSON & CO (BDX) | EVP, CRO & Pres. Life Sciences | Sell | 75 | $14,502 |
| 2025-12-01 | BECTON DICKINSON & CO (BDX) | EVP, CRO & Pres. Life Sciences | Buy | 8,829 | $0 |
| 2025-12-01 | BECTON DICKINSON & CO (BDX) | EVP, CRO & Pres. Life Sciences | Sell | 419 | $0 |
| 2025-10-28 | BECTON DICKINSON & CO (BDX) | EVP & President, Life Sciences | Sell | 57 | $10,603 |
| 2025-09-29 | BECTON DICKINSON & CO (BDX) | EVP & President, Life Sciences | Sell | 58 | $10,500 |
| 2025-08-26 | BECTON DICKINSON & CO (BDX) | EVP & President, Life Sciences | Sell | 57 | $11,285 |
| 2025-08-22 | BECTON DICKINSON & CO (BDX) | EVP & President, Life Sciences | Sell | 773 | $0 |
Source: SEC Form 4 filings · as of 2026-06-26